His research focuses on tumor microenvironment and drug response. His research evaluates the endothelial cell plasticity in different type of cancers. He is Consulting Editor for Pharmacological Research journal.

He serves as Chair of the Oncology Committee.

Her research focuses on immunopharmacology and tumor immunology, with a particular interest in pharmacological strategies to modulate antitumor immunity.

She serves as European Representative on the Oncopharmacology Committee.

His research focuses on the emerging field of cancer neuroscience, with two main areas of interest.

His previous work investigated the neuroprotective effects of several drug candidates in the prevention and treatment of chemotherapy-induced peripheral neuropathies.

With expertise in high-throughput pharmacological screening, his current research focuses on the role of the nervous system in the progression of solid cancers, with a particular interest in understanding how neural/glial signaling contributes to the development of resistance to anticancer treatments.

His research focuses on the tumor microenvironment, especially hypoxic environment. He aims to inhibit cellular hypoxic response of cancers with pharmacological approaches.

His research focuses on the development of novel chemo-immunotherapeutic strategies that integrate conventional chemotherapeutic agents with immunomodulators, with particular emphasis on advancing innovative therapeutic approaches for colorectal and breast cancers.

His research focuses on pancreatic cancer, precision medicine, and the development and clinical validation of diagnostic and prognostic biomarkers, with expertise in metabolomics, multiomics, machine learning, and systems pharmacology.